Literature DB >> 20420477

Diagnosis and subtypes of adolescent antisocial personality disorder.

Meredith Jones1, Drew Westen.   

Abstract

The present study examined the application of the Antisocial Personality Disorder (APD) diagnosis to adolescents and investigated the possibility of subtypes of APD adolescents. As part of a broader study of adolescent personality in clinically-referred patients, experienced clinicians provided personality data on a randomly selected patient in their care using the SWAP-II-A personality pathology instrument. Three hundred thirteen adolescents met adult DSM-IV diagnostic criteria for APD. To characterize adolescents with the disorder, we aggregated the data to identify the items most descriptive and distinctive of APD adolescents relative to other teenagers in the sample (N = 950). Q-factor analysis identified five personality subtypes: psychopathic-like, socially withdrawn, impulsive-histrionic, emotionally dysregulated, and attentionally dysregulated. The five subtypes differed in predictable ways on a set of external criteria related to global adaptive functioning, childhood family environment, and family history of psychiatric illness. Both the APD diagnosis and the empirically derived APD subtypes provided incremental validity over and above the DSM-IV disruptive behavior disorders in predicting global adaptive functioning, number of arrests, early-onset severe externalizing pathology, and quality of peer relationships. Although preliminary, these results provide support for the use of both APD and personality-based subtyping systems in adolescents.

Entities:  

Mesh:

Year:  2010        PMID: 20420477     DOI: 10.1521/pedi.2010.24.2.217

Source DB:  PubMed          Journal:  J Pers Disord        ISSN: 0885-579X


  1 in total

1.  Emotion dysregulation and negative affect: association with psychiatric symptoms.

Authors:  Bekh Bradley; Jared A DeFife; Clifford Guarnaccia; Justine Phifer; Negar Fani; Kerry J Ressler; Drew Westen
Journal:  J Clin Psychiatry       Date:  2011-05       Impact factor: 4.384

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.